FDA OKs Tezspire for Severe Asthma Respiratory Therapy The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and The Amino zing World of Peptide Regulation ArentFox Schiff A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read OncLive's FDA Approval Report: The Regulatory Rundown for March 2025 OncLive